Review ArticleInternational Journal of Contemporary Pediatrics

Publication:
Effectiveness of riboflavin as prophylaxis of paediatric migraine

Int J Contemp Pediatr. 2023;10(12):1881-1885.DOI10.18203/2349-3291.ijcp20233545

Read online (HTML) View on the journal's website(opens in a new tab)

Abstract

Paediatric migraine headache is a common condition for which there is no general consensus on the choice of prophylactic. Riboflavin has been considered as a potential prophylactic which is well tolerated. This review examines the current literature regarding the efficacy of riboflavin as a prophylactic. There have been mixed results from both retrospective studies as well as randomised controlled trials. Whilst the adverse effect profile is minimal compared to other migraine prophylactics, further well-designed studies with larger sample sizes and longer follow-up are required.

Keywords

Affiliations

  1. Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, United Kingdom

Full item record